Print

Covidien (COV) Appoints Richard DeRisio Vice President, Global Quality Assurance and Regulatory Affairs  
3/20/2012 6:09:13 AM

MANSFIELD, Mass.--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the appointment of Richard DeRisio as Vice President, Global Quality Assurance and Regulatory Affairs, effective immediately. He will report directly to Michael Sgrignari, Senior Vice President, Quality & Operations.